The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity
Abstract
The fundamental event in prion diseases seems to be a conformational change in cellular prion protein (PrP C ) whereby it is converted into the pathologic isoform PrP Sc . In fatal familial insomnia (FFI), the protease-resistant fragment of PrP Sc after deglycosylation has a size of 19 kilodaltons, whereas that from other inherited and sporadic prion diseases is 21 kilodaltons. Extracts from the brains of FFI patients transmitted disease to transgenic mice expressing a chimeric human-mouse PrP gene about 200 days after inoculation and induced formation of the 19-kilodalton PrP Sc fragment, whereas extracts from the brains of familial and sporadic Creutzfeldt-Jakob disease patients produced the 21-kilodalton PrP Sc fragment in these mice. The results presented indicate that the conformation of PrP Sc functions as a template in directing the formation of nascent PrP Sc and suggest a mechanism to explain strains of prions where diversity is encrypted in the conformation of PrP Sc .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,277
NMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,043
Self-citationMolecular basis of phenotypic variability in sporadc creudeldt‐jakob disease
Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S. G., Farlow, M., Dickson, D. W., Sima, A. A. F., Trojanowski, J. Q., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390613 · Cited by 864
Self-citationTelling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (1995) · Cell · doi:10.1016/0092-8674(95)90236-8 · Cited by 857
Self-citationLinkage of a prion protein missense variant to Gerstmann–Sträussler syndrome
Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. D., Westaway, D., Ott, J., & Prusiner, S. B. (1989) · Nature · doi:10.1038/338342a0 · Cited by 849
Self-citationCaughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F., & Caughey, W. S. (1991) · Biochemistry · doi:10.1021/bi00245a003 · Cited by 822
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., & Diringer, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3688-3693.1987 · Cited by 766
Goldfarb, L. G., Petersen, R. B., Tabaton, M., Brown, P., LeBlanc, A. C., Montagna, P., Cortelli, P., Julien, J., Vital, C., Pendelbury, W. W., et al. (1992) · Science · doi:10.1126/science.1439789 · Cited by 716
Self-citation
Cited by
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Self-citationTransmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., et al. (1997) · Nature · doi:10.1038/39057 · Cited by 1,967
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils
Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Eight prion strains have PrPSc molecules with different conformations
Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., & Prusiner, S. B. (1998) · Nature Medicine · doi:10.1038/2654 · Cited by 1,245
Self-citationMolecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Paravastu, A. K., Leapman, R. D., Yau, W.-M., & Tycko, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806270105 · Cited by 1,160
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021
Self-citationPrion Diseases and the BSE Crisis
Prusiner, S. B. (1997) · Science · doi:10.1126/science.278.5336.245 · Cited by 954
Self-citationPrusiner, S. B., Scott, M. R., DeArmond, S. J., & Cohen, F. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81163-0 · Cited by 923
Self-citationPrion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
Self-citationConformational variations in an infectious protein determine prion strain differences
Tanaka, M., Chien, P., Naber, N., Cooke, R., & Weissman, J. S. (2004) · Nature · doi:10.1038/nature02392 · Cited by 770
A Transmembrane Form of the Prion Protein in Neurodegenerative Disease
Hegde, R. S., Mastrianni, J. A., Scott, M. R., DeFea, K. A., Tremblay, P., Torchia, M., DeArmond, S. J., Prusiner, S. B., & Lingappa, V. R. (1998) · Science · doi:10.1126/science.279.5352.827 · Cited by 729
Self-citationHill, A., Butterworth, R., Joiner, S., Jackson, G., Rossor, M., Thomas, D., Frosh, A., Tolley, N., Bell, J., Spencer, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12075-5 · Cited by 699
Wadsworth, J., Joiner, S., Hill, A., Campbell, T., Desbruslais, M., Luthert, P., & Collinge, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05403-4 · Cited by 693
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Self-citationGenerating a Prion with Bacterially Expressed Recombinant Prion Protein
Wang, F., Wang, X., Yuan, C.-G., & Ma, J. (2010) · Science · doi:10.1126/science.1183748 · Cited by 661
Scott, M. R., Will, R., Ironside, J., Nguyen, H.-O. B., Tremblay, P., DeArmond, S. J., & Prusiner, S. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15137 · Cited by 596
Self-citationSporadic and familial CJD: classification and characterisation
Gambetti, P., Kong, Q., Zou, W., Parchi, P., & Chen, S. G. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.213 · Cited by 569
Self-citationPATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Self-citationAntibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Self-citationKaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., James, T. L., Cohen, F. E., & Prusiner, S. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10069 · Cited by 515
Self-citationVariant Creutzfeldt-Jakob disease
Collinge, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05128-4 · Cited by 512
Gottlieb, G. (1998) · Psychological Review · doi:10.1037/0033-295x.105.4.792-802 · Cited by 489
Colby, D. W., & Prusiner, S. B. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006833 · Cited by 472
Self-citationJames, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10086 · Cited by 452
Self-citationAmyloid Polymorphism: Structural Basis and Neurobiological Relevance
Tycko, R. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.017 · Cited by 440
Transmission of multiple system atrophy prions to transgenic mice
Watts, J. C., Giles, K., Oehler, A., Middleton, L., Dexter, D. T., Gentleman, S. M., DeArmond, S. J., & Prusiner, S. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318268110 · Cited by 438
Self-citationDarwinian Evolution of Prions in Cell Culture
Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M., & Weissmann, C. (2010) · Science · doi:10.1126/science.1183218 · Cited by 434
Structural studies of the scrapie prion protein by electron crystallography
Wille, H., Michelitsch, M. D., Guénebaut, V., Supattapone, S., Serban, A., Cohen, F. E., Agard, D. A., & Prusiner, S. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052703499 · Cited by 420
Self-citationPrusiner, S. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00171.x · Cited by 392
Self-citationMolecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 367
Asante, E. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf653 · Cited by 357
Familial and sporadic fatal insomnia
Montagna, P., Gambetti, P., Cortelli, P., & Lugaresi, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00323-5 · Cited by 354
Self-citationPhage display technology: clinical applications and recent innovations
Azzazy, H. M. E., & Highsmith, W. E. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00343-0 · Cited by 351
Weissmann, C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1025 · Cited by 346
Peretz, D., Williamson, R. A., Matsunaga, Y., Serban, H., Pinilla, C., Bastidas, R. B., Rozenshteyn, R., James, T. L., Houghten, R. A., Cohen, F. E., et al. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1328 · Cited by 336
Self-citationGenetic influence on the structural variations of the abnormal prion protein
Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., Kopp, N., Schulz-Schaeffer, W. J., Kretzschmar, H. A., Head, M. W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10168 · Cited by 330
Self-citationInsights into prion strains and neurotoxicity
Aguzzi, A., Heikenwalder, M., & Polymenidou, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2204 · Cited by 329
Emerging Principles of Conformation-Based Prion Inheritance
Chien, P., Weissman, J. S., & DePace, A. H. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161837 · Cited by 326
Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein
Caughey, B., Raymond, G. J., & Bessen, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32230 · Cited by 318
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage
Shafiei, S. S., Guerrero-Muñoz, M. J., & Castillo-Carranza, D. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00083 · Cited by 314
From conversion to aggregation: Protofibril formation of the prion protein
DeMarco, M. L., & Daggett, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307178101 · Cited by 314
α-Synuclein strains target distinct brain regions and cell types
Lau, A., So, R. W. L., Lau, H. H. C., Sang, J. C., Ruiz-Riquelme, A., Fleck, S. C., Stuart, E., Menon, S., Visanji, N. P., Meisl, G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0541-x · Cited by 309
Amyloid Structure: Conformational Diversity and Consequences
Toyama, B. H., & Weissman, J. S. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-090908-120656 · Cited by 304
Strain-specific prion-protein conformation determined by metal ions
Wadsworth, J. D. F., Hill, A. F., Joiner, S., Jackson, G. S., Clarke, A. R., & Collinge, J. (1999) · Nature Cell Biology · doi:10.1038/9030 · Cited by 295
Species-barrier-independent prion replication in apparently resistant species
Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L., & Collinge, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10248 · Cited by 295
Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients
Watts, J. C., Condello, C., Stöhr, J., Oehler, A., Lee, J., DeArmond, S. J., Lannfelt, L., Ingelsson, M., Giles, K., & Prusiner, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408900111 · Cited by 282
Self-citationDeadly Conformations—Protein Misfolding in Prion Disease
Horwich, A. L., & Weissman, J. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80232-9 · Cited by 278
Role of tau protein in Alzheimer’s disease: The prime pathological player
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278
Parchi, P., Capellari, S., Chen, S. G., Petersen, R. B., Gambetti, P., Kopp, N., Brown, P., Kitamoto, T., Tateishi, J., Giese, A., et al. (1997) · Nature · doi:10.1038/386232a0 · Cited by 273
Self-citationGlycosylation differences between the normal and pathogenic prion protein isoforms
Rudd, P. M., Endo, T., Colominas, C., Groth, D., Wheeler, S. F., Harvey, D. J., Wormald, M. R., Serban, H., Prusiner, S. B., Kobata, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13044 · Cited by 273
Self-citationA newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes
Le Dur, A., Béringue, V., Andréoletti, O., Reine, F., Laï, T. L., Baron, T., Bratberg, B., Vilotte, J.-L., Sarradin, P., Benestad, S. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502296102 · Cited by 269
A systematic review of prion therapeutics in experimental models
Trevitt, C. R. (2006) · Brain · doi:10.1093/brain/awl150 · Cited by 263
Parchi, P., Strammiello, R., Notari, S., Giese, A., Langeveld, J. P. M., Ladogana, A., Zerr, I., Roncaroli, F., Cras, P., Ghetti, B., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0585-1 · Cited by 263
Self-citationBruce, M. E. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.99 · Cited by 263
Structural polymorphism of Alzheimer Aβ and other amyloid fibrils
Fändrich, M., Meinhardt, J., & Grigorieff, N. (2009) · Prion · doi:10.4161/pri.3.2.8859 · Cited by 258
High-resolution structure and strain comparison of infectious mammalian prions
Kraus, A., Hoyt, F., Schwartz, C. L., Hansen, B., Artikis, E., Hughson, A. G., Raymond, G. J., Race, B., Baron, G. S., & Caughey, B. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.011 · Cited by 258
Yu, J.-R., Lee, C.-H., Oksuz, O., Stafford, J. M., & Reinberg, D. (2019) · Genes & Development · doi:10.1101/gad.325050.119 · Cited by 257
The role of extracellular vesicles in neurodegenerative diseases
Quek, C., & Hill, A. F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.090 · Cited by 213
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Holmes, B. B., & Diamond, M. I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.549295 · Cited by 202
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Colin, M., Dujardin, S., Schraen-Maschke, S., Meno-Tetang, G., Duyckaerts, C., Courade, J.-P., & Buée, L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02087-9 · Cited by 187
Baker, C. A., Martin, D., & Manuelidis, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10905-10913.2002 · Cited by 128
Liberski, P. P., Sikorska, B., Bratosiewicz-Wasik, J., Carleton Gajdusek, D., & Brown, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.016 · Cited by 125
THE PUBLIC HEALTH IMPACT OF PRION DISEASES
Belay, E. D., & Schonberger, L. B. (2005) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144536 · Cited by 116
Choi, C. J., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.06.004 · Cited by 88
Tau prion-like propagation: state of the art and current challenges
Dujardin, S., & Hyman, B. T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_23 · Cited by 84
Bouybayoune, I., Mantovani, S., Del Gallo, F., Bertani, I., Restelli, E., Comerio, L., Tapella, L., Baracchi, F., Fernández-Borges, N., Mangieri, M., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004796 · Cited by 81
Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau
Siddiqua, A., Luo, Y., Meyer, V., Swanson, M. A., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303498q · Cited by 75
Carlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51
Self-citation
Metadata
- Authors
- Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B.
- Venue
- Science
- Published
- 1996-12-20
- Volume
- 274
- Issue
- 5295
- Pages
- 2079-2082
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022614447
- Cited by
- 865
- References
- 43
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.